Scott D. Schroeder

Clinical targeting of HIV capsid protein with a long-acting small molecule

John O. Link, Martin S. Rhee, Winston C. Tse et al. · Nature · 2020 · 392 citations · Full text

Natural Sciences, Human Retrovirus, Immunology +10

A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model

Stephen R. Yant, Andrew Mulato, Derek Hansen et al. · Nature Medicine · 2019 · 157 citations · Full text

Medicine, Human Retrovirus, Immunology +8

Targeting Methanopterin Biosynthesis ToInhibitMethanogenesis

Razvan Dumitru, Hector Palencia, Scott D. Schroeder et al. · Applied and Environmental Microbiology · 2003 · 38 citations · Full text

Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent

Raju Subramanian, Jennifer Tang, Jim Zheng et al. · Molecular Pharmaceutics · 2023 · 38 citations · Full text

Pharmaceutical Science, Pharmacokinetic Modeling, Flip-flop Kinetics +14

Controlling Mode Selectivity in Palladium-Catalyzed Bisdiene Carbocyclizations:  Optimizing for Cyclization-Trapping over Cycloisomerization

James M. Takacs, Scott D. Schroeder, Jianxin Han et al. · Organic Letters · 2003 · 24 citations